2020年ATC肝移植研究前沿盘点  

Summary of the research frontiers of liver transplantation in 2020 ATC

作　　者：李海波 汪国营[1] 蔡建业 冯啸[1] 曾凯宁[1] 杨扬[1] Li Haibo;Wang Guoying;Cai Jianye;Feng Xiao;Zeng Kaining;Yang Yang(Department of Hepatic Surgery,Liver Transplantation Center,the Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China)

机构地区：[1]中山大学附属第三医院肝脏外科暨肝移植中心,广州510630

出　　处：《器官移植》2021年第1期29-36,共8页Organ Transplantation

基　　金：国家“十三五”重大科技专项(2017ZX10203205);广东省科技计划项目(2017B020209004、2019B020236003)。

摘　　要：美国移植年会(ATC)是器官移植领域极具影响力的学术盛会。本文概述了2020年ATC肝移植领域的热点内容,包括供肝获取和质量评估、供肝保存和缺血-再灌注损伤(IRI)、肝细胞癌及其他肝脏恶性肿瘤肝移植、肝移植术后并发症、肝移植免疫学、围手术期管理和供者来源性感染、儿童肝移植、细胞治疗等多个方向的最新研究进展。The American Transplant Congress(ATC)is an influential academic congress in the field of organ transplantation.In this article,the hotspots of liver transplantation in 2020 ATC were summarized,including the latest research progress in donor liver procurement and quality assessment,donor liver preservation and ischemia-reperfusion injury(IRI),liver transplantation for hepatocellular carcinoma and other hepatic malignancies,complications after liver transplantation,transplantation immunology,perioperative management and donor-derived infection,pediatric liver transplantation and cell therapy,etc.

关 键 词：美国移植年会(ATC) 肝移植 供肝获取 供肝保存 感染 肝细胞癌(肝癌)肝移植 儿童肝移植 移植免疫 

分 类 号：R617[医药卫生—外科学] R619.3[医药卫生—临床医学]